Climb Bio (CLYM) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.31
-0.25
-0.19
-0.13

Details

Expected EPS
-0.287921
Actual EPS
-0.2
Surprise EPS
0.09
Surprise Percent
+30.54%

Description

Climb Bio (CLYM) has reported earnings of -0.2 per share for Q2 2026.

0 Comments

Share your thoughts